Charles J. D'adhemar
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.
Journal: Cell death and differentiation
Published: January 27, 2017
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
Journal: PloS one
Published: January 27, 2014
Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.
Journal: International journal of molecular sciences
Published: November 07, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026